Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-02 06:36 am Sale | 13G | PROTALIX BIOTHERAPEUTICS INC C PLX | NACHT MARIUS | 2,208,913 2.9% | -607,988 (-21.58%) | View |
| 2023-01-03 06:01 am Unchanged | 13G | PROTALIX BIOTHERAPEUTICS INC C PLX | NACHT MARIUS | 2,816,901 5.3% | 0 (Unchanged) | View |
| 2022-12-27 09:04 am Unchanged | 13D | BIONDVAX PHARMACEUTICALS LTD. BVXV | NACHT MARIUS | 170,961,770 12.3% | 0 (Unchanged) | View |
| 2022-01-31 07:16 am Sale | 13G | PROTALIX BIOTHERAPEUTICS INC C PLX | NACHT MARIUS | 2,816,901 5.8% | -570,421 (-16.84%) | View |
| 2022-01-11 12:47 pm Unchanged | 13D | BIONDVAX PHARMACEUTICALS LTD. BVXV | NACHT MARIUS | 170,961,770 23.6% | 0 (Unchanged) | View |
| 2021-02-09 06:01 am Unchanged | 13D | BIONDVAX PHARMACEUTICALS LTD. BVXV | NACHT MARIUS | 170,961,770 30.6% | 0 (Unchanged) | View |
| 2021-02-08 06:08 am Purchase | 13G | PROTALIX BIOTHERAPEUTICS INC C PLX | NACHT MARIUS | 3,387,322 9.99% | 99,231 (+3.02%) | View |
| 2020-11-24 06:04 am Purchase | 13G | PROTALIX BIOTHERAPEUTICS INC C PLX | NACHT MARIUS | 3,288,091 9.9% | 3,288,091 (New Position) | View |
| 2019-11-12 06:08 am Purchase | 13D | BIONDVAX PHARMACEUTICALS LTD. BVXV | NACHT MARIUS | 170,961,770 42.49% | 117,200,938 (+218.00%) | View |